APA

Chisholm J. C., Merks J. H. M., Casanova M., Bisogno G., Orbach D., Gentet J., Thomassin-Defachelles A., Chastagner P., Lowis S., Ronghe M., McHugh K., van Rijn R. R., Hilton M., Bachir J., Fürst-Recktenwald S., Geoerger B. & Oberlin O. (20170911). Open-label, multicentre, randomised, phase II study of the EpSSG and the ITCC evaluating the addition of bevacizumab to chemotherapy in childhood and adolescent patients with metastatic soft tissue sarcoma (the BERNIE study). : European journal of cancer (Oxford, England : 1990).

Chicago

Chisholm Julia C, Merks Johannes H M, Casanova Michela, Bisogno Gianni, Orbach Daniel, Gentet Jean-Claude, Thomassin-Defachelles Anne-Sophie, Chastagner Pascal, Lowis Stephen, Ronghe Milind, McHugh Kieran, van Rijn Rick R, Hilton Magalie, Bachir Jeanette, Fürst-Recktenwald Sabine, Geoerger Birgit and Oberlin Odile. 20170911. Open-label, multicentre, randomised, phase II study of the EpSSG and the ITCC evaluating the addition of bevacizumab to chemotherapy in childhood and adolescent patients with metastatic soft tissue sarcoma (the BERNIE study). : European journal of cancer (Oxford, England : 1990).

Harvard

Chisholm J. C., Merks J. H. M., Casanova M., Bisogno G., Orbach D., Gentet J., Thomassin-Defachelles A., Chastagner P., Lowis S., Ronghe M., McHugh K., van Rijn R. R., Hilton M., Bachir J., Fürst-Recktenwald S., Geoerger B. and Oberlin O. (20170911). Open-label, multicentre, randomised, phase II study of the EpSSG and the ITCC evaluating the addition of bevacizumab to chemotherapy in childhood and adolescent patients with metastatic soft tissue sarcoma (the BERNIE study). : European journal of cancer (Oxford, England : 1990).

MLA

Chisholm Julia C, Merks Johannes H M, Casanova Michela, Bisogno Gianni, Orbach Daniel, Gentet Jean-Claude, Thomassin-Defachelles Anne-Sophie, Chastagner Pascal, Lowis Stephen, Ronghe Milind, McHugh Kieran, van Rijn Rick R, Hilton Magalie, Bachir Jeanette, Fürst-Recktenwald Sabine, Geoerger Birgit and Oberlin Odile. Open-label, multicentre, randomised, phase II study of the EpSSG and the ITCC evaluating the addition of bevacizumab to chemotherapy in childhood and adolescent patients with metastatic soft tissue sarcoma (the BERNIE study). : European journal of cancer (Oxford, England : 1990). 20170911.